Buy, hold, sell: BHP, CSL, and Woodside shares

Let's see if analysts are bullish or bearish on these giants.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There are a lot of blue-chip ASX 200 shares to pick from on the Australian share market.

But not all are necessarily buys right now.

So, to narrow things down, let's see what analysts are saying about three of the most popular shares on the ASX 200 index. Here's what you need to know:

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.

Image source: Getty Images

BHP Group Ltd (ASX: BHP)

BHP is the world's largest mining company and a major producer of commodities such as iron ore, copper, and metallurgical coal.

One positive currently working in its favour is the strength in copper prices. Copper is widely viewed as one of the most important commodities for electrification, renewable energy infrastructure, and electric vehicles. With demand expected to rise strongly over the coming decade, BHP's significant exposure to copper could become an increasingly valuable part of its portfolio.

But does this make BHP shares a buy?

Morgan Stanley has an overweight rating on the mining giant with a $56.00 price target. Meanwhile, Ord Minnett has an accumulate rating with a $54.00 price target. This compares favourably to the current BHP share price of $49.39.

CSL Ltd (ASX: CSL)

CSL is one of Australia's largest healthcare companies and a global leader in plasma therapies, vaccines, and biotechnology products.

Unlike some other ASX heavyweights, CSL has not enjoyed much positive momentum recently. Its shares have come under significant pressure and are trading well below their historical highs, which has left the company looking relatively cheap compared to its long-term valuation.

Is this an opportunity to buy a high-quality healthcare business with global operations, a large research pipeline, and strong positions in specialised treatment markets?

Despite its struggles, brokers remain positive on CSL and see value in its shares. Morgans has a buy rating on the healthcare giant with a $241.34 price target, while UBS also has a buy rating and a $235.00 price target. This compares to the current CSL share price of $139.86.

Woodside Energy Group Ltd (ASX: WDS)

Woodside is Australia's largest oil and gas producer and generates the bulk of its earnings from global energy markets.

One of the major positives currently supporting the company is the strength in oil prices, which are trading above US$100 per barrel due to the war in the Middle East. Higher oil prices typically translate into stronger cash flow for energy producers, which can support dividends and investment in new projects.

Does this make Woodside shares a buy?

Well, due to recent share price strength, brokers are largely on the fence with this one. UBS currently has a neutral (hold) rating on the company with a $28.10 price target, while Macquarie also has a neutral rating with a $30.00 price target. This compares to the current Woodside share price of $31.51.

Motley Fool contributor James Mickleboro has positions in CSL and Woodside Energy Group Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended BHP Group and CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Buy, hold, sell: Collins Foods, Netwealth, and Pro Medicus shares

How does the broker rate these popular shares this month?

Read more »

A smiling florist gets some good news on his laptop and tablet.
Broker Notes

What is Morgan's view on Navigator Global Investments shares after update

Morgans sees further upside for this stock.

Read more »

Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.
Broker Notes

What are brokers predicting for BHP shares over the next 12 months?

Have the mining giant's shares reached their peak? Or can they keep climbing? Let's find out.

Read more »

A young woman wearing a red and white striped t-shirt puts her hand to her chin and looks sideways as she wonders whether to buy ASX shares
Broker Notes

Buy, hold, sell: Aristocrat, Lovisa, Bendigo Bank shares

Here's what some experts think.

Read more »

A businesswoman on the phone is shocked as she looks at her watch, she's running out of time.
Broker Notes

Is this ASX 200 share a sell after announcing a $30-40 million EBITA hit?

Morgans has lowered its outlook on Worley shares.

Read more »

Buy, hold, and sell ratings written on signs on a wooden pole.
Broker Notes

Should you buy BHP shares ahead of the miner's production update?

BHP shares could see some big moves after the miner reports its March production results this week.

Read more »

A woman looks questioning as she puts a coin into a piggy bank.
Broker Notes

Buy, hold, or sell? Coles, Wesfarmers, BHP shares

ASX 200 shares are in the red as the global oil shock continues to concern investors.

Read more »

Health professional working on his laptop.
Broker Notes

Are Orthocell shares a buy after crashing 7% yesterday?

These healthcare shares could be on discount right now.

Read more »